Hester Bios

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE782E01017
NSEID: HESTERBIO
BSEID: 524669
View on NSE | View on BSE

INR

1,999.90

65.35 (3.38%)

BSENSE

Jun 11, 11:02 AM

BSE+NSE Vol: 1.89 k

{
  "main_header": {
    "sid": 324228,
    "name": "Hester Bios",
    "stock_name": "Hester Bios",
    "full_name": "Hester Biosciences Ltd",
    "name_url": "stocks-analysis/hester-bios",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,999.90",
    "chg": 65.35,
    "chgp": "3.38%",
    "dir": 1,
    "prev_price": "1,934.55",
    "mcapval": "1,701.29 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524669,
    "symbol": "HESTERBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE782E01017",
    "curr_date": "Jun 11, 11:02 AM",
    "curr_time": "11:04 AM",
    "last_traded_at": "Jun 11, 11:02 AM IST",
    "bse_nse_vol": "1.89 k",
    "exc_status": "Active",
    "traded_date": "Jun 11, 2026",
    "traded_date_str": "2026 06 11",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hester-bios-324228-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4043221",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_technicaldot_4043221.png",
        "date": "2026-06-10 08:01:46",
        "description": "Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent downgrade in daily moving averages to mildly bearish, weekly and monthly signals present a nuanced picture for investors navigating this pharmaceuticals and biotechnology micro-cap."
      },
      {
        "title": "Hester Biosciences Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-financials-4040446",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_mojoScore_4040446.png",
        "date": "2026-06-09 08:32:32",
        "description": "Hester Biosciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a combination of improved technical indicators, solid recent financial performance, and a more favourable valuation outlook. The upgrade, effective from 8 June 2026, is underpinned by positive shifts across four key parameters: quality, valuation, financial trend, and technicals."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4032730",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_technicaldot_4032730.png",
        "date": "2026-06-03 08:01:02",
        "description": "Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock exhibits a complex interplay of technical indicators that suggest cautious optimism amid mixed signals."
      },
      {
        "title": "Hester Biosciences Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4030103",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_mojoScore_4030103.png",
        "date": "2026-06-02 08:36:30",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 1 June 2026. This change reflects a complex interplay of factors across quality, valuation, financial trends, and technical indicators, signalling caution for investors despite pockets of positive performance."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4029230",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/HesterBioscienc_technicaldot_4029230.png",
        "date": "2026-06-02 08:02:16",
        "description": "Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a modest day gain of 0.57%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical developments, price action, and comparative returns to provide a comprehensive view for investors."
      },
      {
        "title": "Hester Biosciences Gains 7.15%: Technical Momentum and Rating Upgrade Drive Weekly Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-gains-715-technical-momentum-and-rating-upgrade-drive-weekly-rally-4024153",
        "imagepath": "",
        "date": "2026-05-31 09:01:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Modest gain of 0.95% as stock trades at Rs.1,885.25</p>\n                    <p><strong>26 May:</strong> Sharp 14.19% surge to Rs.2,152.80; mojo rating upgraded to Hold</p>\n                    <p><strong>27 May:</strong> Technical momentum shifts to mildly bullish amid strong price rally</p>\n                    <p><strong>29 May:</strong> Week closes at Rs.2,000.95, up 7.15% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,867.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><..."
      },
      {
        "title": "Hester Biosciences Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/hester-biosciences-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financial-trends-4015923",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_mojoScore_4015923.png",
        "date": "2026-05-27 08:11:01",
        "description": "Hester Biosciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement in its technical indicators and sustained positive financial performance. The upgrade, effective from 26 May 2026, is driven by enhanced technical trends, solid quarterly results, and a more favourable valuation outlook despite some lingering concerns over long-term growth and debt servicing capacity."
      },
      {
        "title": "Hester Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-sees-technical-momentum-shift-amid-strong-price-rally-4015617",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_technicaldot_4015617.png",
        "date": "2026-05-27 08:01:23",
        "description": "Hester Biosciences Ltd has experienced a significant shift in its technical momentum following a robust price surge of 14.19% in a single trading session. This micro-cap pharmaceutical and biotechnology company has moved from a sideways trend to a mildly bullish stance, supported by a confluence of technical indicators signalling improving market sentiment and potential for further gains."
      },
      {
        "title": "Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/hester-biosciences-ltd-technical-momentum-shifts-amid-mixed-market-signals-4012489",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/HesterBioscienc_technicaldot_4012489.png",
        "date": "2026-05-26 08:01:53",
        "description": "Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of late May 2026. Despite a modest day gain of 0.95%, the stock’s technical indicators present a complex picture, with bullish signals on shorter timeframes contrasting with bearish cues on monthly charts. This nuanced technical landscape, combined with a recent downgrade in its Mojo Grade from Hold to Sell, warrants a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector."
      }
    ],
    "total": 5474,
    "sid": "324228",
    "stock_news_url": "https://www.marketsmojo.com/news/hester-biosciences-324228"
  },
  "announcements": [
    {
      "caption": "Announcement Under Regulation 30 Of Listing Regulations - Disclosure On Amendments In Loan Agreement Of Hester Africa",
      "datetime": "20-May-2026",
      "details": "Announcement under Regulation 30 of Listing Regulation - Amendments in Loan agreement of Hester Africa",
      "source": "BSE"
    },
    {
      "caption": "Intimation Of Submission Of The Reclassification Application Under Regulation 31A Of Listing Regulations",
      "datetime": "20-May-2026",
      "details": "Intimation of Submission of reclassification application with the stock exchanges under Regulations 31A of Listing Regulations",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "18-May-2026",
      "details": "Annual Secretarial Compliance Report for the year ended 31 March 2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has declared <strong>70%</strong> dividend, ex-date: 06 Aug 25",
          "dt": "2025-08-06",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 27 Sep 12",
          "dt": "2012-09-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Hester Biosciences Ltd has announced <strong>2:5</strong> rights issue, ex-date: 29 May 06",
          "dt": "2006-05-29",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-10 08:01:46

Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend, reflecting a complex interplay of technical indicators. Despite a recent downgrade in daily moving averages to mildly bearish, weekly and monthly signals present a nuanced picture for investors navigating this pharmaceuticals and biotechnology micro-cap.

Read full news article

Hester Biosciences Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financials

2026-06-09 08:32:32

Hester Biosciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a combination of improved technical indicators, solid recent financial performance, and a more favourable valuation outlook. The upgrade, effective from 8 June 2026, is underpinned by positive shifts across four key parameters: quality, valuation, financial trend, and technicals.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-03 08:01:02

Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock exhibits a complex interplay of technical indicators that suggest cautious optimism amid mixed signals.

Read full news article

Hester Biosciences Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-06-02 08:36:30

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 1 June 2026. This change reflects a complex interplay of factors across quality, valuation, financial trends, and technical indicators, signalling caution for investors despite pockets of positive performance.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-06-02 08:02:16

Hester Biosciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a modest day gain of 0.57%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum oscillators. This analysis delves into the recent technical developments, price action, and comparative returns to provide a comprehensive view for investors.

Read full news article

Hester Biosciences Gains 7.15%: Technical Momentum and Rating Upgrade Drive Weekly Rally

2026-05-31 09:01:29

Key Events This Week

25 May: Modest gain of 0.95% as stock trades at Rs.1,885.25

26 May: Sharp 14.19% surge to Rs.2,152.80; mojo rating upgraded to Hold

27 May: Technical momentum shifts to mildly bullish amid strong price rally

29 May: Week closes at Rs.2,000.95, up 7.15% for the week

Read full news article

Hester Biosciences Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financial Trends

2026-05-27 08:11:01

Hester Biosciences Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a marked improvement in its technical indicators and sustained positive financial performance. The upgrade, effective from 26 May 2026, is driven by enhanced technical trends, solid quarterly results, and a more favourable valuation outlook despite some lingering concerns over long-term growth and debt servicing capacity.

Read full news article

Hester Biosciences Ltd Sees Technical Momentum Shift Amid Strong Price Rally

2026-05-27 08:01:23

Hester Biosciences Ltd has experienced a significant shift in its technical momentum following a robust price surge of 14.19% in a single trading session. This micro-cap pharmaceutical and biotechnology company has moved from a sideways trend to a mildly bullish stance, supported by a confluence of technical indicators signalling improving market sentiment and potential for further gains.

Read full news article

Hester Biosciences Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-05-26 08:01:53

Hester Biosciences Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend as of late May 2026. Despite a modest day gain of 0.95%, the stock’s technical indicators present a complex picture, with bullish signals on shorter timeframes contrasting with bearish cues on monthly charts. This nuanced technical landscape, combined with a recent downgrade in its Mojo Grade from Hold to Sell, warrants a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector.